Hints and tips:
Related Special Reports
...Costs from healthcare litigation can spiral as any investors in Bayer can vouch for....
...The US government named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs, marking the biggest shake-up for the pharmaceutical industry in decades...
...Ginger Graham, a board member since 2010 and former chief of Amylin Pharmaceuticals, will fill the chief executive role while it searches for “a successor with deep healthcare experience”....
...of pharmaceuticals for the Americas....
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...But the White House’s tough approach on antitrust makes large deals much riskier....
...Results so far include a white paper, and the launch of DBS Betterworld, a metaverse space dedicated to the theme of environmental, social and governance....
...Paul Hastings O: 6; L: 7; I: 7; Total: 20The firm advised South Korean pharmaceutical company SD Biosensor and South Korean private equity fund SJL Partners on the acquisition of US-listed pharmaceutical...
...Rod Wong, chief investment officer at RTW, a New York-based healthcare fund with some China investments said the Legend Biotech white blood cell cancer therapy was a “globally competitive therapy” and part...
...Carri Chan, a professor of healthcare and pharmaceutical management at Columbia Business School, says the pills are “very promising”, comparing them to taking Tamiflu after the initial symptoms of influenza...
...“If [mRNA] does work, you could cede the whole market to Moderna or Pfizer,” said Geoffrey Porges, an analyst at healthcare-focused investment bank SVB Leerink....
...Jeff Zients, head of the White House’s Covid-19 task force, said during a press briefing that, if approved, the pill would be an “additional tool in our toolbox” to address the pandemic....
...Pfizer had a good reason to worry: even many western healthcare providers had struggled to store the shots....
...It is the way that we need to protect individuals and the public,” she said at the BofA Global Healthcare investor conference on Wednesday....
...Another biotech, GL Rapha, will produce doses of Russia’s Sputnik V jab for global use. Additional reporting by Sherry Fei Ju in Beijing...
...So I would just say, it would be better to wait your turn in line,” the 78-year-old US president said in remarks from the White House on Friday, adding that he would get his own booster as soon as he could...
...Neither the White House nor the US health department responded to requests to comment on the rollout of booster shots....
...Tobacco groups have a horrible history, but the healthcare industry is hardly squeaky clean....
...Chief executives rarely consume alcohol at lunch these days, especially pharmaceutical ones. But Albert Bourla has never really fitted the mould of the typical corporate boss....
...Of that 15 per cent, 70 per cent are white and 65 per cent are Republican voters....
...While J&J is the world’s largest healthcare company, it is not nearly as experienced in vaccines as Merck and does not have the same kind of capabilities to produce inoculations at scale....
...His comments came after the White House appeared to suggest the president could be among those to get the vaccine early, alongside healthcare workers and people living and working in care homes....
...The rate reported on Friday by the world’s largest healthcare company is lower than that of jabs that are already authorised from BioNTech/Pfizer, Moderna and Oxford/AstraZeneca....
...Hours after the FDA report, Donald Trump told a vaccine summit at the White House that he was “very hopeful that the FDA will authorise the Pfizer vaccine within days — we’ve got to get it moving”....
...An expensive reputation Many pharmaceutical companies hope the pandemic will burnish reputations that have sometimes been tarred with criticism over drug pricing....
International Edition